Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials

Overview of attention for article published in Advances in Therapy, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,895 followers.

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical https://t.co/gaotJssbKd.

Safety and Tolerability of Empagliflozin in Patients with #Type2Diabetes https://t.co/YSLEIYF7Ka #T2D #clinicaltrials

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.